Clinical data showed that positive LOXL2 expression was associated with tumor proliferation, so the effect of LOXL2 silencing and overexpression on ESCC cell proliferation was examined using the Cell Counting Kit-8 (CCK-8) assay. The gene discussed is LOXL2; the disease is neoplasm.